Smith & Wesson Brands (NASDAQ:SWBI – Get Free Report) posted its earnings results on Thursday. The company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.10, Briefing.com reports. Smith & Wesson Brands had a return on equity of 11.18% and a net margin of 7.39%. The business had revenue of $159.15 million during the quarter, compared to analysts’ expectations of $156.80 million. During the same period in the prior year, the business earned $0.32 EPS. Smith & Wesson Brands’s revenue for the quarter was up 9.9% compared to the same quarter last year.
Smith & Wesson Brands Trading Down 12.9 %
NASDAQ:SWBI opened at $14.29 on Friday. Smith & Wesson Brands has a twelve month low of $10.38 and a twelve month high of $18.05. The company has a quick ratio of 1.42, a current ratio of 3.21 and a debt-to-equity ratio of 0.27. The business has a 50 day moving average price of $16.41 and a two-hundred day moving average price of $15.17. The company has a market cap of $658.77 million, a P/E ratio of 16.62 and a beta of 1.11.
Analysts Set New Price Targets
A number of research firms recently issued reports on SWBI. Lake Street Capital upped their price target on Smith & Wesson Brands from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday. Craig Hallum raised Smith & Wesson Brands from a “hold” rating to a “buy” rating and upped their price target for the stock from $14.00 to $18.00 in a research report on Friday, March 8th.
Smith & Wesson Brands Company Profile
Smith & Wesson Brands, Inc designs, manufactures, and sells firearms worldwide. The company offers handguns, including revolvers and pistols; long guns, such as modern sporting rifles, bolt action rifles; handcuffs; suppressors; and other firearm-related products under the Smith & Wesson, M&P, and Gemtech brands.
Read More
- Five stocks we like better than Smith & Wesson Brands
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- McDonald’s Stock: Balancing Value and Innovation
- How Technical Indicators Can Help You Find Oversold Stocks
- MarketBeat Week in Review – 6/17 – 6/21
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for Smith & Wesson Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Wesson Brands and related companies with MarketBeat.com's FREE daily email newsletter.